The Latest
-
Dexcom to add 2 board directors with activist investor Elliott
CEO Jake Leach also discussed the company’s plans for its G8 glucose sensor, dual-analyte sensing and Medicare coverage at an investor day.
-
Sponsored by Infineon Technologies and Eko Health
Reinventing the stethoscope and cardiopulmonary care
AI-powered smart stethoscopes are making early disease detection easier than ever.
-
Carl Zeiss says restructuring could affect up to 1,000 jobs
A weak investment climate in the Americas contributed to declines in the German company’s intraocular lens business in the first half of its fiscal year.
-
Labcorp expands Epic pact to make full test menu available on Aura
The Labcorp agreement continues the expansion of Aura, which gives healthcare providers access to tests from companies including Quest Diagnostics.
-
Oracle adds Cleveland Clinic CEO to board of directors
Dr. Tomislav Mihaljevic’s appointment comes months after Oracle named former Quest Diagnostics CEO Stephen Rusckowski to the board as the technology giant expands its reach in the healthcare sector.
-
FDA chief Marty Makary resigns from agency, ending tumultuous tenure
Makary’s exit ends a turbulent run marred by leadership upheaval, mass layoffs, political pressure and public spats with drugmakers.
-
4 medtech manufacturers recall kits over problem with Medline syringes
AVID Medical, Aligned Medical Solutions, Medical Action Industries and American Contract Systems all sent notices to customers about convenience kits that contain recalled Medline angiographic syringes.
-
J&J launches improved Shockwave catheter
The latest generation of the coronary intravascular lithotripsy device is designed to be more flexible to help physicians navigate tight arteries to break up calcified deposits and restore blood flow.
-
Artera gets FDA clearance for AI breast cancer risk prediction tool
The company launched in 2023 with $90 million in funding from organizations including Johnson & Johnson’s venture capital arm.
-
Stryker values Amplitude Vascular purchase at up to $835M
The deal for Amplitude’s intravascular lithotripsy platform, which closed last week, includes $435 million upfront and up to $400 million in milestone payments.
-
Bayesian Health gets FDA nod for AI sepsis detection tool
Created by Johns Hopkins University researchers, the early warning system for sepsis aims to help physicians detect the serious condition earlier.
-
HistoSonics seeks FDA de novo authorization in kidney cancer
Investors including Bezos Expeditions and Thiel Bio supported HistoSonics’ expansion plans last year by participating in a $250 million financing round.
-
Retrieved from Medtronic on May 11, 2026
Medtronic to close California site amid restructuring
The decision to wind down the operation in Santa Rosa in about two years comes as the medtech giant combines several businesses within its cardiovascular portfolio.
-
Mobia Medical CEO eyes large market for stroke rehab
With a recent initial public offering, CEO Richard Foust hopes to make the company’s vagus nerve stimulation treatment the standard of care for stroke.
-
BD appoints Vitor Roque as permanent CFO
The company made Roque’s appointment permanent after considering external candidates for the role.
-
Tandem to file tubeless insulin pump with FDA this quarter
The new version of Tandem’s Mobi pump would be the diabetes technology company’s first tubeless device.
-
Retrieved from Stryker Corporation on January 06, 2025
Stryker closes Amplitude Vascular acquisition
With an intravascular lithotripsy platform, Stryker will enter a booming market that has attracted investment from Johnson & Johnson, Boston Scientific and Abbott.
-
Roche to acquire digital pathology firm PathAI for up to $1.05B
Roche plans to offer PathAI’s tools as part of an effort to improve cancer diagnosis and tailored treatment.
-
Trade court rules Trump’s 10% global tariff illegal
Despite saying the levy was “unauthorized by law,” the U.S. Court of International Trade did not issue a universal stay.
Updated May 12, 2026 -
FDA warns of neurosurgical supply disruptions
Interruptions in the supply of neurosurgical patties, sponges and strips are expected to continue through 2026.
-
Neptune Medical’s GI robot succeeds in colonoscopy study
The first-in-human study showed no adverse events and a 100% rate of cecal intubation, where the endoscope is guided to the beginning of the large intestine.
-
Integra reappoints Stuart Essig as CEO
Essig filled the vacancy created when Mojdeh Poul and the Integra board mutually decided to end her time as CEO after less than 18 months.
-
Insulet raises revenue expectations for 2026
CEO Ashley McEvoy also shared an update on the company’s recent recall of insulin patch pumps.
-
J&J’s Ottava robot meets goals in gastric bypass study
The findings for patients 30 days after surgery were included in a package of data supporting J&J’s submission to the FDA for de novo authorization.
-
Retrieved from Viatris on May 05, 2026
Edwards names Theodora Mistras as CFO
Mistras, who joins the heart valve company after two years as CFO at pharmaceutical firm Viatris, also brings investment banking experience.
-
Olympus, EndoRobotics forge distribution pact
The deal to distribute EndoRobotics’ endoscopic robotic devices for gastroenterology follows Olympus’ agreement to co-launch Swan EndoSurgical, a startup developing a robotic GI platform.